Authorized purpose: Post-process previously acquired cervical-spine MR images to segment vertebrae and disks, calculate quantitative measurements, label out-of-range values, and export results for user review and interpretation.
Clinical role
Post-processing segmentation and measurement support with user-defined threshold labeling of out-of-range measurements
Images and patients
MRI · Cervical spine: vertebrae C3-C7 and disks C2C3 through C7T1
Key limitation
Keep in mind: Valid input requires DICOM cervical-spine MR, age 22 or older, and adequate C2-C7 visualization. Performance was not established for vertebral enumeration variants, true cervical ribs, hemivertebrae, congenital or acquired fusion, contrast studies, tumors, infections, post-operative changes, vertebral fusion, or inadequate C2 visualization; the comparison table also describes a non-pregnant patient population.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Post-process previously acquired cervical-spine MR images to segment vertebrae and disks, calculate quantitative measurements, label out-of-range values, and export results for user review and interpretation.
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Cervical spine: vertebrae C3-C7 and disks C2C3 through C7T1 Input: Previously acquired DICOM cervical-spine MR images from patients aged 22 years or older with adequate visualization of C2-C7.
Who uses it?Intended users: Radiologists, spine surgeons, and neurosurgeons
What does the software produce?Output: Segmentation of C3-C7 vertebrae and C2C3-C7T1 disks; measurements based on those segmentations; threshold-based labeling of out-of-range measurements; and export of measurement results. The user remains responsible for reviewing and confirming or modifying settings and outputs.
What is its most important limitation?Key limitation: Valid input requires DICOM cervical-spine MR, age 22 or older, and adequate C2-C7 visualization. Performance was not established for vertebral enumeration variants, true cervical ribs, hemivertebrae, congenital or acquired fusion, contrast studies, tumors, infections, post-operative changes, vertebral fusion, or inadequate C2 visualization; the comparison table also describes a non-pregnant patient population.
Clinical takeaway. Clinical role: Post-process previously acquired cervical-spine MR images to segment vertebrae and disks, calculate quantitative measurements, label out-of-range values, and export results for user review and interpretation.
Evidence takeaway. Evidence from the reviewed source record: A US software performance assessment used 95 cervical-spine MR studies from 95 patients, with ground truth defined by four radiologists. Tissue-segmentation MDC was 0.90 for vertebral body sagittal, 0.84 for disk sagittal, 0.70 for disk material outside the intervertebral space sagittal, and 0.68 for focal disk material outside the intervertebral space axial. Measurement MAE was 0.72 mm for vertebral-body height, 0.90 mm for disk height, 0.72 mm for disk-material AP size, and 1.29 mm for focal disk-material AP size, with the packet's stated 95% CIs.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Post-process previously acquired cervical-spine MR images to segment vertebrae and disks, calculate quantitative measurements, label out-of-range values, and export results for user review and interpretation.
Segmentation of C3-C7 vertebrae and C2C3-C7T1 disks; measurements based on those segmentations; threshold-based labeling of out-of-range measurements; and export of measurement results. The user remains responsible for reviewing and confirming or modifying settings and outputs.
Valid input requires DICOM cervical-spine MR, age 22 or older, and adequate C2-C7 visualization. Performance was not established for vertebral enumeration variants, true cervical ribs, hemivertebrae, congenital or acquired fusion, contrast studies, tumors, infections, post-operative changes, vertebral fusion, or inadequate C2 visualization; the comparison table also describes a non-pregnant patient population.
A US software performance assessment used 95 cervical-spine MR studies from 95 patients, with ground truth defined by four radiologists. Tissue-segmentation MDC was 0.90 for vertebral body sagittal, 0.84 for disk sagittal, 0.70 for disk material outside the intervertebral space sagittal, and 0.68 for focal disk material outside the intervertebral space axial. Measurement MAE was 0.72 mm for vertebral-body height, 0.90 mm for disk height, 0.72 mm for disk-material AP size, and 1.29 mm for focal disk-material AP size, with the packet's stated 95% CIs.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
A US software performance assessment used 95 cervical-spine MR studies from 95 patients, with ground truth defined by four radiologists. Tissue-segmentation MDC was 0.90 for vertebral body sagittal, 0.84 for disk sagittal, 0.70 for disk material outside the intervertebral space sagittal, and 0.68 for focal disk material outside the intervertebral space axial. Measurement MAE was 0.72 mm for vertebral-body height, 0.90 mm for disk height, 0.72 mm for disk-material AP size, and 1.29 mm for focal disk-material AP size, with the packet's stated 95% CIs.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
CoLumbo C-Spine regulatory performance study summary
DesignStand-Alone Performance
PopulationAdult
Scopeexact submission
Tested versionExact product version not reported; regulatory study summarized for FDA submission K254015
Samplen=95
IndependenceIndependence not established
K254015
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K254015. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Previously acquired DICOM cervical-spine MR images from patients aged 22 years or older with adequate visualization of C2-C7.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: FDA materials establish DICOM MR input and export of measurement results for hospital/medical-institution use, but do not establish a specific PACS, RIS, EHR, hosting, or network interface.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-08 ·
Returned objects
Source context, not route validation: Segmentation of C3-C7 vertebrae and C2C3-C7T1 disks; measurements based on those segmentations; threshold-based labeling of out-of-range measurements; and export of measurement results. The user remains responsible for reviewing and confirming or modifying settings and outputs.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Segmentation of C3-C7 vertebrae and C2C3-C7T1 disks; measurements based on those segmentations; threshold-based labeling of out-of-range measurements; and export of measurement results. The user remains responsible for reviewing and confirming or modifying settings and outputs.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
FDA materials establish DICOM MR input and export of measurement results for hospital/medical-institution use, but do not establish a specific PACS, RIS, EHR, hosting, or network interface.
Smart Soft Healthcare announces on the CoLumbo product site that the company received ISO/IEC 27001 certification (stated as ISO/IEC 27001:2017) for its information security management system, covering development and delivery of AI-powered medical imaging solutions such as CoLumbo AI Spine Assistant.
Vendor-wide
Checked 2026-10-27
Vendor statement on the official CoLumbo product site operated for Smart Soft Healthcare (the page states CoLumbo is developed by Smart Soft Healthcare); the certificate itself was not read, and the page states the version as ISO/IEC 27001:2017 as published. Exact-release scope is not established.
ACR AI Central provides an exact-submission model card for CoLumbo C-Spine; FDA labeling remains controlling for clinical use, limitations, and performance.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
23Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission
No public price or quote for the exact K254015 configuration was established in this review.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Deployment: Not verified - checked 2026-09-08 - Exact FDA submission
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-08 - Exact FDA submission
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Authorized purpose: Automatic MRI segmentation and quantitative analysis of muscle, bone, fat, and other anatomical structures to assist visualization and measurement; not direct disease diagnosis.
Modality
MRI
Anatomy
Muscles, bones, and adipose tissue across the lower extremities and upper body from neck to hips, plus other segmented structures
Authorized purpose: Semi-automatic lumbar MRI segmentation and area and distance measurements with radiologist-approved PDF report to PACS; adjunct only.
Authorized purpose: Assist physicians in reviewing previously acquired lumbar-spine MRI by providing user-confirmed anatomy identification, segmentation, labeling, measurements, and reporting; it is not a diagnostic device.
Modality
MRI
Anatomy
Lumbar spine, including vertebral bodies L1-S1, intervertebral discs, cord canal, dural sac, nerve roots, and posterior arch.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.